Proffitt & Goodson’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.49K Hold
43
﹤0.01% 253
2025
Q4
$5.24K Sell
43
-47
-52% -$5.39K ﹤0.01% 258
2025
Q3
$9.02K Hold
90
﹤0.01% 261
2025
Q2
$7.46K Hold
90
﹤0.01% 215
2025
Q1
$7.3K Hold
90
﹤0.01% 211
2024
Q4
$8.11K Hold
90
﹤0.01% 205
2024
Q3
$8.89K Hold
90
﹤0.01% 218
2024
Q2
$8.34K Hold
90
﹤0.01% 230
2024
Q1
$8.54K Hold
90
﹤0.01% 197
2023
Q4
$8.04K Hold
90
﹤0.01% 190
2023
Q3
$6.57K Hold
90
﹤0.01% 198
2023
Q2
$7.49K Hold
90
﹤0.01% 192
2023
Q1
$6.86K Hold
90
﹤0.01% 200
2022
Q4
$7.47K Hold
90
﹤0.01% 201
2022
Q3
$7K Hold
90
﹤0.01% 211
2022
Q2
$7K Hold
90
﹤0.01% 221
2022
Q1
$8K Buy
+90
New +$8.31K ﹤0.01% 235
2016
Q1
Sell
-17,015
Closed -$1.19M 45
2015
Q4
$1.19M Sell
17,015
-595
-3% -$40.6K 0.7% 22
2015
Q3
$1.1M Sell
17,610
-3,855
-18% -$304K 0.69% 25
2015
Q2
$1.8M Sell
21,465
-1,425
-6% -$111K 1.05% 10
2015
Q1
$1.72M Sell
22,890
-2,076
-8% -$145K 1% 10
2014
Q4
$1.55M Sell
24,966
-1,572
-6% -$89.6K 0.92% 12
2014
Q3
$1.38M Sell
26,538
-690
-3% -$35.2K 0.85% 15
2014
Q2
$1.4M Buy
27,228
+45
+0.2% +$2.03K 0.84% 17
2014
Q1
$1.29M Sell
27,183
-876
-3% -$44.8K 0.83% 21
2013
Q4
$1.22M Buy
28,059
+606
+2% +$25.1K 0.79% 23
2013
Q3
$1.18M Sell
27,453
-1,935
-7% -$78.4K 0.85% 16
2013
Q2
$1.02M Buy
+29,388
New +$1.03M 0.79% 26

Other funds holding XBI